MLFP
BIB icon

MPS Loria Financial Planners’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

MPS Loria Financial Planners’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100
Closed -$8K – 152
2021
Q1 		$8K Hold
100
– – ﹤0.01% 308
2020
Q4 		$9K Buy
+100
New +$7.74K ﹤0.01% 304

Other funds holding BIB

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UMC
United Maritime Capital New York $15.2M AUM 45.42% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return

MPS Loria Financial Planners's BIB Position: Q2 2021 in Review

MPS Loria Financial Planners sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q2 2021, closing a stake of 100 shares — an estimated $8K sold.

MPS Loria Financial Planners first reported a position in BIB in Q4 2020 and held it in 2 quarters. The position peaked at $9K in Q4 2020. 36 funds tracked by Wall St. Rank hold BIB as of Q2 2021.

  • MPS Loria Financial Planners reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q2 2021 after selling out during the quarter.
  • MPS Loria Financial Planners sold 100 ProShares Ultra NASDAQ Biotechnology shares in Q2 2021, an estimated $8K.
  • MPS Loria Financial Planners first reported a position in ProShares Ultra NASDAQ Biotechnology in Q4 2020 and held it in 2 quarters.
  • MPS Loria Financial Planners's ProShares Ultra NASDAQ Biotechnology position peaked at $9K in Q4 2020.
  • 36 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2021.

Based on MPS Loria Financial Planners's 13F filing for Q2 2021, filed 20 Jul 2021.